Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Dabrafenib & Melanoma (cutaneous) (BRAF m), dabrafenib is approved in the United States as a treatment for patients with unresectable or metastatic Melanoma (cutaneous) (BRAF m). It is used as a single agent in these cases. Additionally, it has received a positive opinion in the European Union for this indication. In the US, the application of dabrafenib included the treatment of this specific population, as identified by a test approved by the US FDA (1).
Dabrafenib has been shown to have high response rates with a rap…